ArticleScientific reports2020

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.

María Rosa López-Huertas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.